Ledger.Open graph →
SEC Form D · filed March 3, 2021

Excision BioTherapeutics Inc

Offering
$10.5M
Sold
$10.5M
Exemption
Rule 506(b)
Industry
Biotechnology
Location
SAN FRANCISCO, CA
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (12)

Daniel Dornbusch · San Francisco, CAExec · DirectorVasudev Bailey · San Francisco, CADirectorWilliam Carson · San Francisco, CADirectorAshok Krishnamurthi · San Francisco, CADirectorDaniel Nocera · Natick, MADirectorJ. Paul Austin · Natick, MADirectorWilliam Brady · Natick, MADirectorHarrison Yoon · Natick, MAExec · DirectorMichael D. Baker · Newark, NJDirectorKristen A. Rivers · Larchmont, NYDirectorRyan D. Smith · Larchmont, NYDirectorPeter Treadway · Larchmont, NYExec · Director

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗